Optical Coherence Tomography Reveals Retinal Neuroaxonal Thinning in Frontotemporal Dementia as in Alzheimer's Disease

被引:91
|
作者
Ferrari, Laura [1 ,2 ]
Huang, Su-Chun [3 ]
Magnani, Giuseppe [1 ,2 ]
Ambrosi, Alessandro [3 ]
Comi, Giancarlo [1 ,2 ,3 ]
Leocani, Letizia [1 ,2 ,3 ]
机构
[1] Ist Sci San Raffaele, Dept Neurol, Milan, Italy
[2] Ist Sci San Raffaele, Inst Expt Neurol, INSPE, Milan, Italy
[3] Univ Vita Salute San Raffaele, Milan, Italy
关键词
Alzheimer's disease; frontotemporal dementia; ganglion cell layer; optical coherence tomography; retinal nerve fiber layer; NERVE-FIBER LAYER; MILD COGNITIVE IMPAIRMENT; MOUSE MODEL; THICKNESS; DEGENERATION; PATHOLOGY; ABNORMALITIES; GUIDELINES; DIAGNOSIS; BIOMARKER;
D O I
10.3233/JAD-160886
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Alzheimer's disease (AD) and frontotemporal dementia (FTD) are leading causes of cognitive decline. Optical coherence tomography (OCT) allows the measurement of thickness of retinal neuroaxonal layers. While in AD and mild cognitive impairment (MCI), retinal nerve fiber layer (RNFL) thinning is frequently reported, less information is available on ganglion cell layer-inner plexiform layer (GCL-IPL). Data on FTD are lacking. Objective: To obtain cross-sectional information on RNFL and GCL-IPL thickness among MCI, AD, FTD, and healthy controls (HC), and their correlations with dementia severity. Methods: Peripapillary OCT scans were obtained in 27 MCI, 39 AD, 17 FTD, 49 HC using high-definition Heidelberg Spectral-domain OCT, with RNFL and GCL-IPL thickness measurement. Statistical analysis tested group effects and correlation with gender, disease duration and severity (Mini-Mental State Examination, MMSE). Results: RNFL showed a significant group effect [F(4,132) = 3.786, p = 0.006], being reduced versus controls in MCI (p = 0.033), moderate AD (p = 0.025), and FTD (p < 0.001), and versus mild AD in FTD (p = 0.042). GCL-IPL showed a significant group effect as well [F(4,121) = 5.104, p < 0.001], with reduction in moderate AD versus HC (p < 0.001), MCI (p = 0.037), and mild AD (p = 0.009); in FTD versus HC (p = 0.002) and mild AD (p = 0.038). In AD, GCL-IPL correlated with MMSE (r = 0.487, p = 0.003), without significant effects of age, gender, or disease duration. Conclusion: Retinal neuroaxonal thinning occurs in MCI/AD consistently with previous reports, as well as in FTD. Correlation with disease severity in AD suggests that retinal and brain neurodegeneration may occur in parallel to some extent, and prompts larger studies aimed at providing surrogate endpoints for clinical trials in AD.
引用
收藏
页码:1101 / 1107
页数:7
相关论文
共 50 条
  • [31] Role of optical coherence tomography in diagnosis of Alzheimer's disease
    Castro-Roger, Luisa
    Mallen, Victor
    Palomar, Elisa Vilades
    Ciordia, Beatriz Cordon
    Altabas, Maria Jose Vicente
    Tello, Alvaro
    Rodrigo, Maria Jesus
    Perie, Manuel Subias
    Campo, Lorena Arias
    Munuera, Ines
    Garcia-Martin, Elena
    ACTA OPHTHALMOLOGICA, 2022, 100
  • [32] Optical coherence tomography angiography in preclinical Alzheimer's disease
    van de Kreeke, Jacoba Alida
    Nguyen, Hoang-Ton
    Konijnenberg, Elles
    Tomassen, Jori
    den Braber, Anouk
    ten Kate, Mara
    Yaqub, Maqsood
    van Berckel, Bart
    Lammertsma, Adriaan A.
    Boomsma, Dorret I.
    Tan, Stevie H.
    Verbraak, Frank
    Visser, Pieter Jelle
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2020, 104 (02) : 157 - 161
  • [33] Optical Coherence Tomography Angiography in Preclinical Alzheimer's Disease
    van de Kreeke, Aleid
    Nguyen, H. Ton
    Konijnenberg, Elles
    Tomassen, Jori
    den Braber, Anouk
    ten Kate, Mara
    Yaqub, Maqsood
    van Berckel, Bart
    Boomsma, Dorret I.
    Tan, H. Stevie
    Visser, Pieter Jelle
    Verbraak, Frank D.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [34] Optical Coherence Tomography Angiography in Preclinical Alzheimer's Disease
    van de Kreeke, J. A.
    Nguyen, H. T.
    Konijnenberg, E.
    Tomassen, J.
    den Braber, A.
    ten Kate, M.
    Yaqub, M.
    van Berckel, B.
    Boomsma, D. I.
    Tan, H. S.
    Visser, P. J.
    Verbraak, F. D.
    ACTA OPHTHALMOLOGICA, 2019, 97 : 33 - 33
  • [35] Behaviour in frontotemporal dementia, Alzheimer's disease and vascular dementia
    Bathgate, D
    Snowden, JS
    Varma, A
    Blackshaw, A
    Neary, D
    ACTA NEUROLOGICA SCANDINAVICA, 2001, 103 (06): : 367 - 378
  • [36] Dementia: Not Only Alzheimer's Disease, an Eye on Frontotemporal Dementia
    Galimberti, Daniela
    Scarpini, Elio
    ACTA MEDICA PORTUGUESA, 2013, 26 (04): : 299 - 300
  • [37] Evaluation of optical coherence tomography angiographic findings in Alzheimer's type dementia
    Bulut, Mehmet
    Kurtulus, Fatma
    Gozkaya, Onursal
    Erol, Muhammet Kazim
    Cengiz, Ayse
    Akidan, Melih
    Yaman, Aylin
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2018, 102 (02) : 233 - 237
  • [38] Combination of snapshot hyperspectral retinal imaging and optical coherence tomography to identify Alzheimer’s disease patients
    Sophie Lemmens
    Toon Van Craenendonck
    Jan Van Eijgen
    Lies De Groef
    Rose Bruffaerts
    Danilo Andrade de Jesus
    Wouter Charle
    Murali Jayapala
    Gordana Sunaric-Mégevand
    Arnout Standaert
    Jan Theunis
    Karel Van Keer
    Mathieu Vandenbulcke
    Lieve Moons
    Rik Vandenberghe
    Patrick De Boever
    Ingeborg Stalmans
    Alzheimer's Research & Therapy, 12
  • [39] Combination of snapshot hyperspectral retinal imaging and optical coherence tomography to identify Alzheimer's disease patients
    Lemmens, Sophie
    Van Craenendonck, Toon
    Van Eijgen, Jan
    De Groef, Lies
    Bruffaerts, Rose
    de Jesus, Danilo Andrade
    Charle, Wouter
    Jayapala, Murali
    Sunaric-Megevand, Gordana
    Standaert, Arnout
    Theunis, Jan
    Van Keer, Karel
    Vandenbulcke, Mathieu
    Moons, Lieve
    Vandenberghe, Rik
    De Boever, Patrick
    Stalmans, Ingeborg
    ALZHEIMERS RESEARCH & THERAPY, 2020, 12 (01)
  • [40] Reliability and validity of Cirrus and Spectralis optical coherence tomography for detecting retinal atrophy in Alzheimer's disease
    Polo, V.
    Garcia-Martin, E.
    Bambo, M. P.
    Pinilla, J.
    Larrosa, J. M.
    Satue, M.
    Otin, S.
    Pablo, L. E.
    EYE, 2014, 28 (06) : 680 - 690